"A good company" is not Amarin
They have proven time and time again that they are a terrible company due to terrible leadership. Incremental steps in refreshing the C-suite and the board have led us nowhere, but people are still delusional that "this time it's different" with a small change in leadership.
This isn't to say Vascepa is worthless, but considering how the key facets of making Amarin a good company have failed to materialize, despite these "refreshes" it is impossible for one to believe that adding a couple people hand picked by the people who suck will help. Celebrating the most basic of successes while ignoring glaring failures like massively overspending in Germany then retroactively claiming they knew they wouldn't get reimbursement right now is insane.
Also, how does 26 million shares give Denner the board? He'd need 180-210+ million shares to be guaranteed the board (67% of the outstanding, depending on exactly which share count is considered the full amount when it comes to tallying votes).
Market Data 
Markets 
AI
